98-887. General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting  

  • [Federal Register Volume 63, Number 9 (Wednesday, January 14, 1998)]
    [Notices]
    [Page 2249]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-887]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    General and Plastic Surgery Devices Panel of the Medical Devices 
    Advisory Committee; Notice of Meeting
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
        This notice announces a forthcoming meeting of a public advisory 
    committee of the Food and Drug Administration (FDA). At least one 
    portion of the meeting may be closed to the public.
        Name of Committee: General and Plastic Surgery Devices Panel of the 
    Medical Devices Advisory Committee.
        General Function of the Committee: To provide advice and 
    recommendations to the agency on FDA regulatory issues.
        Date and Time: The meeting will be held on January 29, 1998, 8:45 
    a.m. to 6 p.m., and January 30, 1998, 8:45 a.m. to 1:30 p.m.
        Location: Gaithersburg Marriott Washingtonian Center, 9751 
    Washingtonian Blvd., Salons F and G, Gaithersburg, MD.
        Contact Person: Gail G. Gantt, Center for Devices and Radiological 
    Health (HFZ-410), Food and Drug Administration, 9200 Corporate Blvd., 
    Rockville, MD 20850, 301-594-3090, or FDA Advisory Committee 
    Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
    area), code 12519. Please call the Information Line or access the 
    Internet address of http://www.fda.gov.cdrh for up-to-date information 
    on this meeting.
        Agenda: On January 29, 1998, the committee will discuss, make 
    recommendations, and vote on one premarket approval application (PMA) 
    for a wound dressing for use on diabetic foot ulcers and a second PMA 
    for a wound dressing for use on venous stasis ulcers. On January 30, 
    1998, the committee will discuss, make recommendations, and vote on a 
    PMA for a skin adhesive for wound edge approximation.
        Procedure: On January 29, 1998 from 8:45 a.m. to 10 a.m and from 11 
    a.m. to 6 p.m., and on January 30, 1998, from 8:45 a.m. to 1:30 p.m., 
    the meeting is open to the public. Interested persons may present data, 
    information, or views, orally or in writing, on issues pending before 
    the committee. Written submissions may be made to the contact person by 
    January 22, 1998. Oral presentations from the public will be scheduled 
    between approximately 8:45 a.m. and 9:45 a.m. on January 29 and 30, 
    1998. Time allotted for each presentation may be limited. Those 
    desiring to make formal oral presentations should notify the contact 
    person before January 22, 1998, and submit a brief statement of the 
    general nature of the evidence or arguments they wish to present, the 
    names and addresses of proposed participants, and an indication of the 
    approximate time requested to make their presentation.
        Closed Presentation of Data: On January 29, 1998, from 10 a.m to 11 
    a.m. the meeting may be closed to permit discussion and review of trade 
    secret and/or confidential information presented by the PMA sponsor(s) 
    (5 U.S.C. 552b(c )(4)).
        FDA regrets that it was unable to publish this notice 15 days prior 
    to the January 29 and 30, 1998, General and Plastic Surgery Devices 
    Panel of the Medical Devices Advisory Committee meeting. Because the 
    agency believes there is some urgency to bring this issue to public 
    discussion and qualified members of the General and Plastic Surgery 
    Devices Panel of the Medical Devices Advisory Committee were available 
    at this time, the Commissioner concluded that it was in the public 
    interest to hold this meeting even if there was not sufficient time for 
    the customary 15-day public notice.
        Notice of this meeting is given under the Federal Advisory 
    Committee Act (5 U.S.C., app. 2).
    
        Dated: January 8, 1998.
     Michael A. Friedman,
     Deputy Commissioner for Operations.
    [FR Doc. 98-887 Filed 1-9-98; 1:52 pm]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
01/14/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-887
Pages:
2249-2249 (1 pages)
PDF File:
98-887.pdf